-
Scheffler opens with bogeys while McIlroy pars at windy US Open
-
Brazil turn corner but tougher World Cup tests await
-
Ronaldinho coming out of retirement to join Italian 3rd division side
-
Cerundolo sees off Nakashima to set up Queen's final with Paul
-
Real Madrid say no contact with Bayern's Olise
-
Fritz takes down Zverev again to reach Halle final
-
Heartbreak for Japanese ace Satono Reve as Almeraq wins Royal Ascot thriller
-
Hendy quick-fire double sweeps Northampton to Prem title
-
Injured Doris out of Ireland's Nations Championship squad
-
'Not ridiculous': US dreams of World Cup glory after big wins
-
Kolbe star goal kicker as Springboks put 80 past Barbarians
-
Pogacar pips Van der Poel to Swiss Tour TT win
-
Bolivia declares state of emergency and begins removing protester roadblocks
-
Ukraine's Zelensky, top officials return Polish awards in WWII row
-
Cerundolo sees off Nakashima to reach Queen's final
-
Jamieson double rocks England at start of record run-chase
-
Pegula powers past Sabalenka to reach Berlin final
-
Funeral for art giant David Hockney already taken place: publicist
-
Krishna and Jaiswal power India to ODI sweep against Afghanistan
-
Red heat alert issued for third of France, alcohol banned at music festival
-
Bagnaia scorches to Czech MotoGP sprint victory, Bezzecchi crashes
-
Trump escalates spat with Italy’s Meloni over G7 photo claim
-
New Zealand set England record 463 to win second Test
-
Driver killed, 28 in hospital as UK train collision probed
-
Diplomats hold US-Iran preparatory discussions at Swiss retreat
-
New Zealand pile on the runs to leave England facing record chase in 2nd Test
-
Shahidi hits ton but India bowl out Afghanistan for 218
-
Court bans Spanish PM's wife from leaving country
-
Israel strikes south Lebanon despite truce announced with Hezbollah
-
Japan's Ogura smashes own track record to take Czech MotoGP pole
-
Hurricanes blow away Chiefs in record-breaking Super Rugby final
-
Germany meet Ivory Coast in high-stakes World Cup clash, Sweden face Dutch
-
Ancient Greek theatre revives legendary Callas opera Medea
-
Indian guru urges broader view of yoga
-
Portugal's unofficial exorcism fever worries Church
-
Paraguay's Almiron sent off under new FIFA 'mouth-covering' rule
-
Ancelotti hails 'complete game' as Brazil sink Haiti at World Cup
-
Tunisia ask how Sweden World Cup star Ayari slipped its net
-
Scotland remain bullish despite Morocco World Cup setback
-
USA down Australia to reach World Cup knockout rounds, Brazil swat Haiti
-
Brazil cruise past Haiti to re-ignite World Cup campaign
-
Australia detects first case of contagious H5 bird flu
-
Scheffler career Slam chances blowing in Shinnecock winds
-
Iran's treatment at World Cup 'a dark point' for football: official
-
McIlroy seven back but likes his chances at US Open
-
Nagelsmann eyes same German lineup against I. Coast after Curacao trouncing
-
Clark leads US Open by four with major champs in the hunt
-
Saibari early strike gives Morocco World Cup win over Scotland
-
Archaeologists discover 'never before seen' pre-Hispanic ruins in Mexico
-
Pochettino backs 'high IQ' players to block out World Cup hype
US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
L.E.Campos--PC